From an analysis of more than 46,000 women, scientists from the University of Aberdeen in the United Kingdom found that ladies who had ever used oral contraceptive tablets were at lower risk of colorectal, ovarian, and endometrial cancers, compared to ladies who had actually never used the pill. Moreover, the study discovered no link between the use of oral contraceptives during reproductive years and increased danger of new cancers in later life. The research study was led by Dr. Lisa Iversen, of the Institute of Applied Health Sciences at Aberdeen, and the findings were recently released in the American Journal of Obstetrics and Gynaecology. According to the Centers for Disease Control and Prevention (CDC), around 16 percent of females in the United States aged in between 15 and 44 years are currently using oral contraceptive pills as an approach of birth control. The “combined tablet” is the most common kind of contraceptive pill utilized. This includes synthetic variations of the hormonal agents estrogen and progesterone. Since naturally happening estrogen and progesterone have been associated with cancer advancement, various studies have examined whether contraceptive pills may play a role in cancer risk. While s.
The Centers for Illness Control and Avoidance (CDC) report that nearly 21,000 females in the United States were diagnosed with ovarian cancer in 2013, and more than 14,000 died from the illness. Early detection of ovarian cancer is vital in improving the patients’ survival rate. If the cancer is identified in the early stages – that is, before it has spread out beyond the ovaries – the survival rate is estimated at 92 percent. However, according to the American Cancer Society, only 15 percent of ovarian cancers are identified this early. New research study by an international team of scientists from the United Kingdom, the U.S., and Australia recognizes 12 genetic variations that raise the likelihood of epithelial ovarian cancer. Epithelial ovarian cancer (EOC) is the most common kind of ovarian cancer. It forms in the epithelium (the tissue) that covers the ovaries. The outcomes of the brand-new genomic study were released in the journal Nature Genes. The new research study was performed as part of the OncoArray Consortium – a large genomic study taking a look at nearly 450,000 samples in an attempt to identify the hereditary background for a lot of common cancers. The OncoArray Consortium utilized an unique genotyping t.
See all stories on this subject